Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · Real-Time Price · USD
20.76
+1.32 (6.79%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Cidara Therapeutics Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$38.00
Upside
+83.04%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +68.59% | Apr 10, 2025 |
| Citizens Capital Markets | Citizens Capital Markets | Buy Initiates $46 | Buy | Initiates | $46 | +121.58% | Mar 12, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $24 → $35 | Strong Buy | Maintains | $24 → $35 | +68.59% | Mar 10, 2025 |
| Needham | Needham | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +68.59% | Mar 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 27, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $34 | Buy | Initiates | $34 | +63.78% | Dec 13, 2024 |
| WBB Securities | WBB Securities | Strong Buy Maintains $40 → $45 | Strong Buy | Maintains | $40 → $45 | +116.76% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +15.61% | Nov 11, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +58.96% | Nov 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +15.61% | Oct 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $24 | Strong Buy | Reiterates | $24 | +15.61% | Sep 16, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold → Strong Buy Upgrades $24 | Hold → Strong Buy | Upgrades | $24 | +15.61% | Aug 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 14, 2024 |
| Needham | Needham | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +20.42% | Aug 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $25 | Strong Buy | Reiterates | $25 | +20.42% | May 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.